Allianz Asset Management Gmb H Alkermes Plc. Transaction History
Allianz Asset Management Gmb H
- $69.7 Billion
- Q3 2024
A detailed history of Allianz Asset Management Gmb H transactions in Alkermes Plc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 32,300 shares of ALKS stock, worth $952,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,300
Previous 41,947
23.0%
Holding current value
$952,850
Previous $1.01 Million
10.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ALKS
# of Institutions
362Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$859 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$560 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$383 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$373 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$271 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.85B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...